Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of 18.52% is in line with its 5-year average of 18.97%, near the high end of its 5-year range (-45.11%–29.38%).
9.40% above its 12-month average of 16.93%.
Reported quarterly EBITDA margin; no daily interpolation. Q2 FY2026 (2026-06-30): 14.00%.
EBITDA MARGIN
18.52%
EBITDA MARGIN AVG TTM
16.93%
EBITDA MARGIN AVG 3Y
16.42%
EBITDA MARGIN AVG 5Y
18.97%
EBITDA MARGIN AVG 10Y
N/A
EBITDA MARGIN AVG 15Y
N/A
EBITDA MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+9.40%
CURRENT VS 3Y AVG
+12.76%
CURRENT VS 5Y AVG
-2.38%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Market Cap
$1.52B
EBITDA Margin
5.15%
TTM Avg
0.72%
3Y Avg
-7.50%
5Y Avg
-11313.48%
Market Cap
$1.65B
EBITDA Margin
0.06%
TTM Avg
-4.29%
3Y Avg
-15.38%
5Y Avg
-22.40%
Market Cap
$1.65B
EBITDA Margin
19.54%
TTM Avg
15.33%
3Y Avg
15.07%
5Y Avg
12.91%
Market Cap
$1.46B
EBITDA Margin
21.45%
TTM Avg
-50.92%
3Y Avg
-538.26%
5Y Avg
-378.46%
Market Cap
$1.43B
EBITDA Margin
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.71B
EBITDA Margin
16.41%
TTM Avg
1.22%
3Y Avg
-1.65%
5Y Avg
4.31%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Certara, Inc. (CERT) | $1.57B | 18.52% | 16.93% | 16.42% | 18.97% |
| Eton Pharmaceuticals, Inc. (ETON)vs › | $1.52B | 5.15% | 0.72% | -7.50% | -11313.48% |
| GH Research PLC (GHRS)vs › | $1.52B | N/A | N/A | N/A | N/A |
| Braveheart Bio, Inc. (BRVE)vs › | $1.51B | N/A | N/A | N/A | N/A |
| Alphatec Holdings, Inc. (ATEC)vs › | $1.65B | 0.06% | -4.29% | -15.38% | -22.40% |
| ANI Pharmaceuticals, Inc. (ANIP)vs › | $1.65B | 19.54% | 15.33% | 15.07% | 12.91% |
| AnaptysBio, Inc. (ANAB)vs › | $1.46B | 21.45% | -50.92% | -538.26% | -378.46% |
| Hemab Therapeutics Holdings, Inc. Common Stock (COAG)vs › | $1.43B | N/A | N/A | N/A | N/A |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $1.71B | 16.41% | 1.22% | -1.65% | 4.31% |
| Alignment Healthcare, Inc. (ALHC)vs › | $1.76B | 1.15% | -0.80% | -3.79% | -4.67% |
Gross Margin
58.3%
EBITDA Margin
18.5%
Operating Margin
1.9%
Net Margin
-16.8%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2026-06-30 | 14.00% |
| 2026-03-31 | 21.55% |
| 2025-12-31 | 1.29% |
| 2025-09-30 | 20.68% |
| 2025-06-30 | 27.13% |
| 2025-03-31 | 24.75% |
| 2024-12-31 | 24.13% |
| 2024-09-30 | 3.20% |
| 2024-06-30 | 8.10% |
| 2024-03-31 | 15.67% |
| 2023-12-31 | 7.23% |
| 2023-09-30 | -45.11% |
| 2023-06-30 | 29.38% |
| 2023-03-31 | 23.21% |
| 2022-12-31 | 28.31% |
| 2022-09-30 | 28.48% |
| 2022-06-30 | 20.88% |
| 2022-03-31 | 23.38% |
| 2021-12-31 | 21.81% |
| 2021-09-30 | 13.50% |
| 2021-06-30 | 22.76% |
| 2021-03-31 | 24.47% |
| 2020-12-31 | -65.60% |
| 2020-09-30 | 29.95% |
| 2020-06-30 | 39.58% |
| 2020-03-31 | 32.17% |
| 2019-12-31 | 27.79% |
| 2019-09-30 | 34.11% |
| 2019-06-30 | 30.22% |
| 2019-03-31 | 30.22% |
